nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—melanoma	0.486	1	CbGaD
Tetrahydrobiopterin—NOS3—umbilical vein—melanoma	0.018	0.134	CbGeAlD
Tetrahydrobiopterin—NOS3—hindlimb—melanoma	0.0165	0.123	CbGeAlD
Tetrahydrobiopterin—NOS3—appendage—melanoma	0.0141	0.105	CbGeAlD
Tetrahydrobiopterin—TH—blood vessel—melanoma	0.00874	0.0653	CbGeAlD
Tetrahydrobiopterin—NOS3—endothelium—melanoma	0.00853	0.0637	CbGeAlD
Tetrahydrobiopterin—NOS3—blood vessel—melanoma	0.00787	0.0587	CbGeAlD
Tetrahydrobiopterin—PTGS2—leg—melanoma	0.00585	0.0436	CbGeAlD
Tetrahydrobiopterin—NOS3—neck—melanoma	0.00563	0.042	CbGeAlD
Tetrahydrobiopterin—TPH1—head—melanoma	0.00555	0.0414	CbGeAlD
Tetrahydrobiopterin—PTGS2—hindlimb—melanoma	0.00522	0.039	CbGeAlD
Tetrahydrobiopterin—TH—eye—melanoma	0.00465	0.0347	CbGeAlD
Tetrahydrobiopterin—TH—retina—melanoma	0.00461	0.0344	CbGeAlD
Tetrahydrobiopterin—PTGS2—appendage—melanoma	0.00448	0.0334	CbGeAlD
Tetrahydrobiopterin—PAH—head—melanoma	0.00435	0.0325	CbGeAlD
Tetrahydrobiopterin—PTGS2—skin epidermis—melanoma	0.00373	0.0278	CbGeAlD
Tetrahydrobiopterin—PTGS2—endothelium—melanoma	0.0027	0.0202	CbGeAlD
Tetrahydrobiopterin—TH—head—melanoma	0.00264	0.0197	CbGeAlD
Tetrahydrobiopterin—PTGS2—blood vessel—melanoma	0.00249	0.0186	CbGeAlD
Tetrahydrobiopterin—NOS3—head—melanoma	0.00238	0.0177	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—melanoma	0.00185	0.0138	CbGeAlD
Tetrahydrobiopterin—Infestation NOS—Vemurafenib—melanoma	0.00178	0.0188	CcSEcCtD
Tetrahydrobiopterin—Infestation—Vemurafenib—melanoma	0.00178	0.0188	CcSEcCtD
Tetrahydrobiopterin—NOS3—lymph node—melanoma	0.00166	0.0124	CbGeAlD
Tetrahydrobiopterin—Respiratory failure—Temozolomide—melanoma	0.00165	0.0175	CcSEcCtD
Tetrahydrobiopterin—Pharyngolaryngeal pain—Docetaxel—melanoma	0.0016	0.0169	CcSEcCtD
Tetrahydrobiopterin—Laryngeal pain—Docetaxel—melanoma	0.00158	0.0168	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Vemurafenib—melanoma	0.00157	0.0166	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Vemurafenib—melanoma	0.00144	0.0152	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Vemurafenib—melanoma	0.00139	0.0147	CcSEcCtD
Tetrahydrobiopterin—Rhinorrhoea—Docetaxel—melanoma	0.00133	0.0141	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Temozolomide—melanoma	0.00129	0.0137	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00122	0.0129	CcSEcCtD
Tetrahydrobiopterin—Cough—Vemurafenib—melanoma	0.00121	0.0128	CcSEcCtD
Tetrahydrobiopterin—Oropharyngeal pain—Docetaxel—melanoma	0.00119	0.0126	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Vemurafenib—melanoma	0.00118	0.0125	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00117	0.0124	CcSEcCtD
Tetrahydrobiopterin—PTGS2—skin of body—melanoma	0.00115	0.00862	CbGeAlD
Tetrahydrobiopterin—Anaphylactic shock—Vemurafenib—melanoma	0.00113	0.012	CcSEcCtD
Tetrahydrobiopterin—Infection—Vemurafenib—melanoma	0.00113	0.0119	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Vemurafenib—melanoma	0.00111	0.0118	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Vemurafenib—melanoma	0.0011	0.0117	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Docetaxel—melanoma	0.0011	0.0116	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Bleomycin—melanoma	0.00106	0.0112	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Bleomycin—melanoma	0.00106	0.0112	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Dactinomycin—melanoma	0.00105	0.0111	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00103	0.0109	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Carmustine—melanoma	0.000986	0.0104	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000979	0.0104	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Temozolomide—melanoma	0.000953	0.0101	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Temozolomide—melanoma	0.000947	0.01	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Carmustine—melanoma	0.000914	0.00967	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Temozolomide—melanoma	0.000909	0.00961	CcSEcCtD
Tetrahydrobiopterin—Infestation—Temozolomide—melanoma	0.000909	0.00961	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vemurafenib—melanoma	0.000897	0.00948	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Dactinomycin—melanoma	0.000895	0.00947	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Temozolomide—melanoma	0.000883	0.00934	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vemurafenib—melanoma	0.000836	0.00884	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Carmustine—melanoma	0.000832	0.0088	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Temozolomide—melanoma	0.00081	0.00856	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Temozolomide—melanoma	0.000804	0.0085	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000784	0.00829	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vemurafenib—melanoma	0.000776	0.00821	CcSEcCtD
Tetrahydrobiopterin—PTGS2—head—melanoma	0.000753	0.00562	CbGeAlD
Tetrahydrobiopterin—Dizziness—Vemurafenib—melanoma	0.00075	0.00793	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Temozolomide—melanoma	0.000735	0.00778	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Carmustine—melanoma	0.000735	0.00777	CcSEcCtD
Tetrahydrobiopterin—Cough—Bleomycin—melanoma	0.000735	0.00777	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vemurafenib—melanoma	0.000721	0.00763	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Docetaxel—melanoma	0.000716	0.00758	CcSEcCtD
Tetrahydrobiopterin—Rash—Vemurafenib—melanoma	0.000715	0.00756	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vemurafenib—melanoma	0.000714	0.00756	CcSEcCtD
Tetrahydrobiopterin—Headache—Vemurafenib—melanoma	0.00071	0.00751	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Temozolomide—melanoma	0.00071	0.00751	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Docetaxel—melanoma	0.000701	0.00742	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Bleomycin—melanoma	0.000687	0.00727	CcSEcCtD
Tetrahydrobiopterin—Infection—Bleomycin—melanoma	0.000683	0.00722	CcSEcCtD
Tetrahydrobiopterin—Agitation—Carmustine—melanoma	0.000675	0.00714	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vemurafenib—melanoma	0.000674	0.00713	CcSEcCtD
Tetrahydrobiopterin—Agitation—Temozolomide—melanoma	0.000653	0.0069	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Carmustine—melanoma	0.000637	0.00673	CcSEcCtD
Tetrahydrobiopterin—Infection—Dactinomycin—melanoma	0.000637	0.00673	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Docetaxel—melanoma	0.000634	0.0067	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000626	0.00662	CcSEcCtD
Tetrahydrobiopterin—Cough—Temozolomide—melanoma	0.00062	0.00655	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Temozolomide—melanoma	0.000615	0.00651	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Temozolomide—melanoma	0.000605	0.0064	CcSEcCtD
Tetrahydrobiopterin—Infestation—Docetaxel—melanoma	0.000604	0.00639	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Docetaxel—melanoma	0.000604	0.00639	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0006	0.00635	CcSEcCtD
Tetrahydrobiopterin—Infection—Carmustine—melanoma	0.000596	0.0063	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Docetaxel—melanoma	0.000596	0.0063	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Docetaxel—melanoma	0.000592	0.00627	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000584	0.00618	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Temozolomide—melanoma	0.00058	0.00613	CcSEcCtD
Tetrahydrobiopterin—Infection—Temozolomide—melanoma	0.000576	0.00609	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Temozolomide—melanoma	0.000568	0.00601	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Temozolomide—melanoma	0.000563	0.00595	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Carmustine—melanoma	0.000546	0.00578	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Bleomycin—melanoma	0.000543	0.00575	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Docetaxel—melanoma	0.000538	0.0057	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Docetaxel—melanoma	0.000534	0.00565	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000528	0.00559	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymph node—melanoma	0.000527	0.00394	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal pain—Dactinomycin—melanoma	0.000524	0.00554	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Carmustine—melanoma	0.000518	0.00548	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Temozolomide—melanoma	0.00051	0.0054	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dactinomycin—melanoma	0.000507	0.00536	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dactinomycin—melanoma	0.000507	0.00536	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Bleomycin—melanoma	0.000506	0.00535	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Temozolomide—melanoma	0.0005	0.00529	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Carmustine—melanoma	0.00049	0.00519	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Docetaxel—melanoma	0.000489	0.00517	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Carmustine—melanoma	0.000474	0.00501	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Carmustine—melanoma	0.000474	0.00501	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Temozolomide—melanoma	0.000474	0.00501	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Docetaxel—melanoma	0.000472	0.005	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dactinomycin—melanoma	0.000472	0.00499	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Temozolomide—melanoma	0.000458	0.00485	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Temozolomide—melanoma	0.000458	0.00485	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Carmustine—melanoma	0.000442	0.00467	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dactinomycin—melanoma	0.000438	0.00464	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Bleomycin—melanoma	0.000437	0.00462	CcSEcCtD
Tetrahydrobiopterin—Rash—Bleomycin—melanoma	0.000433	0.00458	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Bleomycin—melanoma	0.000433	0.00458	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Temozolomide—melanoma	0.000427	0.00452	CcSEcCtD
Tetrahydrobiopterin—Cough—Docetaxel—melanoma	0.000412	0.00436	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Carmustine—melanoma	0.00041	0.00434	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Docetaxel—melanoma	0.000409	0.00433	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bleomycin—melanoma	0.000408	0.00432	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dactinomycin—melanoma	0.000407	0.00431	CcSEcCtD
Tetrahydrobiopterin—Rash—Dactinomycin—melanoma	0.000404	0.00427	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Docetaxel—melanoma	0.000402	0.00425	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000399	0.00422	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Carmustine—melanoma	0.000397	0.0042	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Temozolomide—melanoma	0.000397	0.00419	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Docetaxel—melanoma	0.000385	0.00408	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Temozolomide—melanoma	0.000383	0.00405	CcSEcCtD
Tetrahydrobiopterin—Infection—Docetaxel—melanoma	0.000383	0.00405	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Carmustine—melanoma	0.000381	0.00403	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dactinomycin—melanoma	0.000381	0.00403	CcSEcCtD
Tetrahydrobiopterin—Rash—Carmustine—melanoma	0.000378	0.004	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Docetaxel—melanoma	0.000378	0.004	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Carmustine—melanoma	0.000378	0.004	CcSEcCtD
Tetrahydrobiopterin—Headache—Carmustine—melanoma	0.000376	0.00397	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Docetaxel—melanoma	0.000374	0.00396	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Temozolomide—melanoma	0.000369	0.0039	CcSEcCtD
Tetrahydrobiopterin—Rash—Temozolomide—melanoma	0.000365	0.00387	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Temozolomide—melanoma	0.000365	0.00386	CcSEcCtD
Tetrahydrobiopterin—Headache—Temozolomide—melanoma	0.000363	0.00384	CcSEcCtD
Tetrahydrobiopterin—Nausea—Carmustine—melanoma	0.000356	0.00377	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000351	0.00371	CcSEcCtD
Tetrahydrobiopterin—Nausea—Temozolomide—melanoma	0.000344	0.00364	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Docetaxel—melanoma	0.000339	0.00359	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Docetaxel—melanoma	0.000333	0.00352	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Docetaxel—melanoma	0.000315	0.00333	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Docetaxel—melanoma	0.000305	0.00322	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Docetaxel—melanoma	0.000305	0.00322	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Docetaxel—melanoma	0.000284	0.003	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Docetaxel—melanoma	0.000264	0.00279	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Docetaxel—melanoma	0.000255	0.0027	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Docetaxel—melanoma	0.000245	0.00259	CcSEcCtD
Tetrahydrobiopterin—Rash—Docetaxel—melanoma	0.000243	0.00257	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Docetaxel—melanoma	0.000243	0.00257	CcSEcCtD
Tetrahydrobiopterin—Headache—Docetaxel—melanoma	0.000241	0.00255	CcSEcCtD
Tetrahydrobiopterin—Nausea—Docetaxel—melanoma	0.000229	0.00242	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HDAC2—melanoma	4.52e-05	0.000159	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO4—melanoma	4.52e-05	0.000159	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCR4—melanoma	4.52e-05	0.000159	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—melanoma	4.49e-05	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNAQ—melanoma	4.47e-05	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—melanoma	4.45e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.44e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NRAS—melanoma	4.43e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.43e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN1A—melanoma	4.43e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTEN—melanoma	4.42e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.41e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CG—melanoma	4.39e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TERT—melanoma	4.31e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HLA-A—melanoma	4.31e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RAC1—melanoma	4.3e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PHGDH—melanoma	4.29e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LUM—melanoma	4.29e-05	0.000151	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CB—melanoma	4.28e-05	0.00015	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK3—melanoma	4.25e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—melanoma	4.24e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PPARG—melanoma	4.24e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ABCB1—melanoma	4.22e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HPSE—melanoma	4.21e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SYK—melanoma	4.2e-05	0.000147	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CUBN—melanoma	4.13e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT3—melanoma	4.13e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ITGAV—melanoma	4.13e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NGFR—melanoma	4.13e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HIF1A—melanoma	4.12e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—melanoma	4.07e-05	0.000143	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK1—melanoma	4.04e-05	0.000142	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SDHD—melanoma	3.99e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CSPG4—melanoma	3.99e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—BSG—melanoma	3.99e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—STAT3—melanoma	3.95e-05	0.000139	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—melanoma	3.94e-05	0.000138	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PRKCA—melanoma	3.89e-05	0.000136	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPAM—melanoma	3.87e-05	0.000136	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CD—melanoma	3.86e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ERCC2—melanoma	3.85e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SOCS1—melanoma	3.82e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—melanoma	3.82e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—S100B—melanoma	3.81e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ALB—melanoma	3.81e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HDAC6—melanoma	3.81e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.79e-05	0.000133	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK3—melanoma	3.78e-05	0.000132	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NOS2—melanoma	3.75e-05	0.000132	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NOTCH1—melanoma	3.72e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—melanoma	3.7e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.68e-05	0.000129	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—melanoma	3.67e-05	0.000129	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB4—melanoma	3.64e-05	0.000128	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD80—melanoma	3.64e-05	0.000128	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APC—melanoma	3.63e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KIT—melanoma	3.63e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN2B—melanoma	3.61e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NPPA—melanoma	3.61e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.6e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.6e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK1—melanoma	3.59e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGF—melanoma	3.59e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—melanoma	3.59e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—melanoma	3.57e-05	0.000125	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—VCAN—melanoma	3.53e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—melanoma	3.51e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—WNT5A—melanoma	3.5e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CD86—melanoma	3.49e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EDN1—melanoma	3.47e-05	0.000122	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.43e-05	0.00012	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—melanoma	3.42e-05	0.00012	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.4e-05	0.000119	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—melanoma	3.39e-05	0.000119	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—melanoma	3.39e-05	0.000119	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CSF2—melanoma	3.39e-05	0.000119	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGF1—melanoma	3.39e-05	0.000119	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—melanoma	3.36e-05	0.000118	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—melanoma	3.33e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—E2F1—melanoma	3.32e-05	0.000116	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PLA2G6—melanoma	3.29e-05	0.000115	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PDGFRA—melanoma	3.28e-05	0.000115	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ITGB3—melanoma	3.25e-05	0.000114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PRKCA—melanoma	3.25e-05	0.000114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—melanoma	3.24e-05	0.000114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAP2K1—melanoma	3.22e-05	0.000113	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—melanoma	3.19e-05	0.000112	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SPP1—melanoma	3.19e-05	0.000112	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAP2K2—melanoma	3.18e-05	0.000111	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.13e-05	0.00011	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—melanoma	3.12e-05	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FGF2—melanoma	3.06e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—melanoma	3.04e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.02e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—melanoma	3.02e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RAC1—melanoma	3.01e-05	0.000106	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—VCAN—melanoma	2.95e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARG—melanoma	2.94e-05	0.000103	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—melanoma	2.92e-05	0.000102	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—melanoma	2.91e-05	0.000102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—melanoma	2.89e-05	0.000101	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—melanoma	2.88e-05	0.000101	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—melanoma	2.86e-05	0.0001	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MDM2—melanoma	2.86e-05	0.0001	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—melanoma	2.82e-05	9.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GAB2—melanoma	2.81e-05	9.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.79e-05	9.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—melanoma	2.78e-05	9.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—melanoma	2.78e-05	9.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KDR—melanoma	2.76e-05	9.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—melanoma	2.76e-05	9.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—melanoma	2.76e-05	9.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FASN—melanoma	2.75e-05	9.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.7e-05	9.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—melanoma	2.68e-05	9.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FN1—melanoma	2.66e-05	9.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—melanoma	2.64e-05	9.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HDAC2—melanoma	2.64e-05	9.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO4—melanoma	2.64e-05	9.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CXCR4—melanoma	2.64e-05	9.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—melanoma	2.61e-05	9.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD44—melanoma	2.61e-05	9.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—melanoma	2.61e-05	9.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NOTCH1—melanoma	2.6e-05	9.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.55e-05	8.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CD80—melanoma	2.55e-05	8.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—melanoma	2.55e-05	8.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—melanoma	2.54e-05	8.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APC—melanoma	2.54e-05	8.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—melanoma	2.54e-05	8.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGF—melanoma	2.52e-05	8.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP17A1—melanoma	2.49e-05	8.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CTNNB1—melanoma	2.47e-05	8.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.46e-05	8.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.43e-05	8.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1A—melanoma	2.41e-05	8.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT3—melanoma	2.41e-05	8.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—melanoma	2.41e-05	8.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—melanoma	2.39e-05	8.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNA11—melanoma	2.35e-05	8.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—melanoma	2.33e-05	8.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—melanoma	2.33e-05	8.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—melanoma	2.31e-05	8.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FASN—melanoma	2.3e-05	8.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—melanoma	2.26e-05	7.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAP2K1—melanoma	2.25e-05	7.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—melanoma	2.24e-05	7.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CD44—melanoma	2.19e-05	7.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNAQ—melanoma	2.19e-05	7.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—melanoma	2.15e-05	7.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—melanoma	2.15e-05	7.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGF2—melanoma	2.14e-05	7.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.14e-05	7.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—melanoma	2.13e-05	7.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB4—melanoma	2.13e-05	7.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN2B—melanoma	2.11e-05	7.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1B1—melanoma	2.1e-05	7.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK3—melanoma	2.06e-05	7.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—melanoma	2.05e-05	7.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD86—melanoma	2.04e-05	7.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—melanoma	2.01e-05	7.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—melanoma	2e-05	7.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—melanoma	2e-05	7.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF1—melanoma	1.98e-05	6.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—melanoma	1.98e-05	6.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK1—melanoma	1.96e-05	6.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—melanoma	1.96e-05	6.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—melanoma	1.95e-05	6.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFRA—melanoma	1.92e-05	6.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKCA—melanoma	1.9e-05	6.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERCC2—melanoma	1.88e-05	6.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—melanoma	1.87e-05	6.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAP2K2—melanoma	1.85e-05	6.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.85e-05	6.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—melanoma	1.85e-05	6.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—melanoma	1.83e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—melanoma	1.79e-05	6.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—melanoma	1.79e-05	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—melanoma	1.76e-05	6.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HLA-A—melanoma	1.76e-05	6.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RAC1—melanoma	1.76e-05	6.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—melanoma	1.75e-05	6.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CTNNB1—melanoma	1.73e-05	6.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—melanoma	1.73e-05	6.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—melanoma	1.7e-05	5.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—melanoma	1.69e-05	5.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1A—melanoma	1.69e-05	5.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—melanoma	1.69e-05	5.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—melanoma	1.68e-05	5.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NFKB1—melanoma	1.68e-05	5.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—melanoma	1.68e-05	5.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PRKCA—melanoma	1.59e-05	5.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ERCC2—melanoma	1.58e-05	5.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—melanoma	1.57e-05	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS2—melanoma	1.53e-05	5.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—melanoma	1.52e-05	5.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOTCH1—melanoma	1.52e-05	5.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—melanoma	1.51e-05	5.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—melanoma	1.5e-05	5.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—melanoma	1.5e-05	5.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD80—melanoma	1.49e-05	5.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—melanoma	1.49e-05	5.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APC—melanoma	1.49e-05	5.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGF—melanoma	1.47e-05	5.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK3—melanoma	1.44e-05	5.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—melanoma	1.42e-05	4.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—melanoma	1.4e-05	4.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—melanoma	1.4e-05	4.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—melanoma	1.39e-05	4.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK1—melanoma	1.37e-05	4.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—melanoma	1.37e-05	4.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAP2K1—melanoma	1.32e-05	4.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—melanoma	1.31e-05	4.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.31e-05	4.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—melanoma	1.29e-05	4.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF2—melanoma	1.25e-05	4.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—melanoma	1.24e-05	4.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARG—melanoma	1.2e-05	4.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—melanoma	1.19e-05	4.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—melanoma	1.17e-05	4.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—melanoma	1.16e-05	4.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—melanoma	1.15e-05	4.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—melanoma	1.15e-05	4.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—melanoma	1.14e-05	3.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—melanoma	1.14e-05	3.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—melanoma	1.1e-05	3.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—melanoma	1.09e-05	3.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—melanoma	1.08e-05	3.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—melanoma	1.07e-05	3.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—melanoma	1.05e-05	3.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CTNNB1—melanoma	1.01e-05	3.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1A—melanoma	9.86e-06	3.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—melanoma	9.84e-06	3.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—melanoma	9.71e-06	3.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—melanoma	9.54e-06	3.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—melanoma	8.8e-06	3.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—melanoma	8.78e-06	3.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK3—melanoma	8.41e-06	2.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—melanoma	8.24e-06	2.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—melanoma	8.18e-06	2.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK1—melanoma	8e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—melanoma	8e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—melanoma	7.56e-06	2.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—melanoma	6.94e-06	2.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—melanoma	6.42e-06	2.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—melanoma	6.15e-06	2.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—melanoma	5.81e-06	2.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—melanoma	5.67e-06	1.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—melanoma	4.75e-06	1.67e-05	CbGpPWpGaD
